OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 39 filers reported holding OCUPHIRE PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,775,904 | -24.7% | 828,628 | -2.4% | 0.18% | -15.8% |
| Q2 2023 | $3,685,901 | +21.5% | 849,286 | +5.0% | 0.21% | +21.5% |
| Q1 2023 | $3,034,189 | +6.6% | 809,117 | +0.4% | 0.17% | +5.5% |
| Q4 2022 | $2,845,417 | +162.0% | 806,067 | +49.2% | 0.16% | +158.7% |
| Q3 2022 | $1,086,000 | +72.7% | 540,348 | +65.0% | 0.06% | +110.0% |
| Q2 2022 | $629,000 | +33.8% | 327,494 | +125.8% | 0.03% | +57.9% |
| Q1 2022 | $470,000 | -4.9% | 145,026 | +9.5% | 0.02% | +5.6% |
| Q4 2021 | $494,000 | – | 132,433 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Regency Capital Management Inc.\DE | 15,000 | $79,000 | 0.06% |
| Ikarian Capital, LLC | 119,551 | $632,000 | 0.05% |
| NORRIS PERNE & FRENCH LLP/MI | 78,909 | $417,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,445 | $124,000 | 0.02% |
| Stokes Family Office, LLC | 12,120 | $64,000 | 0.01% |
| MARSHALL WACE, LLP | 329,131 | $1,738,000 | 0.01% |
| Cornerstone Capital, Inc. | 11,357 | $60,000 | 0.01% |
| MCF Advisors LLC | 9,499 | $50,000 | 0.01% |
| Cutler Group LLC / CA | 7,900 | $41,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 13,389 | $71,000 | 0.00% |